Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
BellBrook
Transcreener AMP2/GMP2 TR-FRET Assay
CHF 0.00
In stock
BBL-3020-1K1000 assaysCHF 1'045.00
BBL-3020-10K10000 assaysCHF 5'334.00
BBL-3020-100K10 x 10000 assaysINQ
Figure 1: Schematic overview of Transcreener AMP2/GMP2 TR-FRET Assay.
| Product Details | |
|---|---|
| Product Type | Kit |
| Properties | |
| Application Set | Compound Screening |
| Crossreactivity | All |
| Quantity |
1000 assays/384wells (BBL-3020-1K) 10000 assays/384wells (BBL-3020-10K) Note: The exact number of assays depends on enzyme reaction conditions. |
| Sensitivity | Excellent data quality (Z’ ≥0.7) at low substrate conversion (10-30%). |
| Range | Accommodates substrate concentrations ranging from 0.1 µM to 1,000 µM. |
| Detection Type | TR-FRET |
| Kit Contains |
AMP/GMP HiLyte647 Tracer, AMP2/GMP2 Antibody-Terbium Conjugate, Tris Solution, AMP, GMP Note: The plates are not included, please see manual for material not provided but necessary for assay. |
| Other Product Data |
Click here for Complete Information from the Original Manufacturer
Easy-to-Use (mix-and-read method).Simple homogenous biochemical assay. Direct unlabeled AMP or GMP from a PDE reaction eliminates laborious coupling steps. Non-radioactive assay technique. HTS Compatible with 96, 384, and 1536-well plates. One assay, hundreds of targets! |
| Declaration | Manufactured by BellBrook Labs. |
| Shipping and Handling | |
| Shipping | DRY ICE |
| Short Term Storage | -20°C |
| Long Term Storage | -20°C |
| Handling Advice | Avoid freeze/thaw cycles. |
| Documents | |
| Manual |
 Download PDF |
| MSDS | Inquire |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
The Transcreener® HTS Assay platform overcomes the need for time-consuming, one-off assay development for individual members within a group transfer enzyme family by utilizing a single set of assay reagents that detect an invariant product. The generic nature of the Transcreener® HTS Assay platform eliminates delays involved in assay development for new HTS targets, and greatly simplifies compound and inhibitor profiling across multiple target families. Transcreener assays have been validated with major HTS instruments to determine the optimal filters and settings for maximal assay performance. Application notes with all important details are available.
The Transcreener® AMP2/GMP2 assay is available in two fluorescent readouts, Fluorescence polarization (FP) and Time-resolved Forster-resonance-energy-transfer (TR-FRET), which provide a safe HTS-compatible alternative to cumbersome radioassay methods and are more sensitive and less subject to interference than other detection methods. Both readouts use far-red tracers to minimize compound interference and lower false-positive rates.
The Transcreener® AMP2/GMP2 TR-FRET Assay (Prod. No. BBL-3020) is competitive immunoassay with a far-red TR-FRET readout. The assay relies on a highly specific monoclonal antibody that recognizes AMP or GMP with more than 1,000-fold selectivity over substrate nucleotides, including ATP, cAMP, or cGMP. The assay can be used with any enzyme that produces AMP or GMP, regardless of the substrate. Examples of enzymes include ubiquitin, small ubiquitin-related modifiers (SUMO), nucleic acid and protein ligases, phosphodiesterases (PDEs), and synthetases. The Transcreener® AMP2/GMP2 FP Assay is a simple one step homogenous detection assay, and is extremely flexible with regard to substrate concentrations (0.1 to 1,000 μM). The assay provides excellent quality with a Z’ = 0.7 at low substrate conversion (typically 10-30%).
Related Products
